IAIM
CLVS

International Assets Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

International Assets Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-856
Closed -$4K – 2101
2021
Q1 		$4K Hold
856
– – ﹤0.01% 1889
2020
Q4 		$4K Buy
+856
New +$4.33K ﹤0.01% 1748

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

International Assets Investment Management's CLVS Position: Q2 2021 in Review

International Assets Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 856 shares — an estimated $4K sold.

International Assets Investment Management first reported a position in CLVS in Q4 2020 and held it in 2 quarters. The position peaked at $4K in Q1 2021. 161 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

  • International Assets Investment Management reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 856 Clovis Oncology, Inc. shares in Q2 2021, an estimated $4K.
  • International Assets Investment Management first reported a position in Clovis Oncology, Inc. in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Clovis Oncology, Inc. position peaked at $4K in Q1 2021.
  • 161 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.